Dual antibiotic prevention bundle is associated with decreased surgical site infections
- 29 July 2020
- journal article
- research article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 30 (9), 1411-1417
- https://doi.org/10.1136/ijgc-2020-001515
Abstract
Background Gynecologic oncology surgery is associated with a wide variation in surgical site infection risk. The optimal method for infection prevention in this heterogeneous population remains uncertain. Study Design A retrospective cohort study was performed to compare surgical site infection rates for patients undergoing hysterectomy over a 1-year period surrounding the implementation of an institutional infection prevention bundle. The bundle comprised pre-operative, intra-operative, and post-operative interventions including a dual-agent antibiotic surgical prophylaxis with cefazolin and metronidazole. Cohorts consisted of patients undergoing surgery during the 6 months prior to this intervention (pre-bundle) versus those undergoing surgery during the 6 months following the intervention (post-bundle). Secondary outcomes included length of stay, readmission rates, compliance measures, and infection microbiology. Data were compared with pre-specified one-sided exact test, Chi-square test, Fisher’s exact test, or Kruskal–Wallis test as appropriate. Results A total of 358 patients were included (178 PRE, 180 POST). Median age was 58 (range 23–90) years. The post-bundle cohort had a 58% reduction in surgical site infection rate, 3.3% POST vs 7.9% PRE (−4.5%, 95% CI −9.3% to −0.2%, p=0.049) as well as reductions in organ space infection, 0.6% POST vs 4.5% PRE (−3.9%, 95% CI −7.2% to −0.7%, p=0.019), and readmission rates, 2.2% POST vs 6.7% PRE (−4.5%, 95% CI −8.7% to −0.2%, p=0.04). Gram-positive, Gram-negative, and anaerobic bacteria were all prevalent in surgical site infection cultures. There were no monomicrobial infections in post-cohort cultures (0% POST vs 58% PRE, p=0.04). No infections contained methicillin-resistant Staphylococcus aureus. Conclusion Implementation of a dual antibiotic infection prevention bundle was associated with a 58% reduction in surgical site infection rate after hysterectomy in a surgically diverse gynecologic oncology practice.Keywords
This publication has 25 references indexed in Scilit:
- Predictors of Surgical Site Infection in Women Undergoing Hysterectomy for Benign Gynecologic Disease: A Multicenter Analysis Using the National Surgical Quality Improvement Program DataJournal of Minimally Invasive Gynecology, 2014
- Surgical Site Infection in Women Undergoing Surgery for Gynecologic CancerInternational Journal of Gynecologic Cancer, 2014
- Prevention of Surgical Site Infection: Beyond SCIPAORN Journal, 2014
- Committee Opinion No. 571Obstetrics & Gynecology, 2013
- Predictors and costs of surgical site infections in patients with endometrial cancerGynecologic Oncology, 2013
- Clinical practice guidelines for antimicrobial prophylaxis in surgeryAmerican Journal of Health-System Pharmacy, 2013
- Strategies to Prevent Surgical Site Infections in Acute Care HospitalsInfection Control & Hospital Epidemiology, 2008
- A randomized trial that compared povidone iodine and chlorhexidine as antiseptics for vaginal hysterectomyAmerican Journal of Obstetrics and Gynecology, 2005
- Does Pre- and Postoperative Metronidazole Treatment Lower Vaginal Cuff Infection Rate After Abdominal Hysterectomy Among Women With Bacterial Vaginosis?Infectious Diseases in Obstetrics and Gynecology, 2002
- Surgical wound infection rates by wound class, operative procedure, and patient risk indexThe American Journal of Medicine, 1991